21 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Scaling-up Packages of Interventions for Cardiovascular disease prevention in selected sites in Europe and Sub-Saharan Africa: An implementation research (SPICES Project) (SPICES)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,
The overall research objective of the SPICES project is to implement and evaluate a comprehensive CVD prevention and control program in five settings: a rural & semi-urban community in a low-income country (Uganda), middle income (South Africa) and vulnerable groups in three high-income countries (Belgium, France and United Kingdom) as well as to identify and compare the barriers and facilitators ...
Voir le projet
6
Participants partenaires
TERMINÉ
ORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs (ORTHOUNION)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,
Current orthopaedic treatments permit spontaneous bone regeneration to unite and heal 90% bone injuries. Non-union associates pain and disability, often requiring biological enhancement. Regenerative medicine research suggests to the general public that alternative treatments based on advanced therapy medicinal products (ATMP) are already available. However, early clinical trials only explore its ...
Voir le projet
13
Participants partenaires
TERMINÉ
Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone (FAIR-PARK-II)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2020,
... moderate-dose DFP (30 mg/kg/day) slows the progression of handicap in de novo PD patients while not affecting systemic parameters. The 9-month, parallel-group, randomized, placebo-controlled, multicentre trial will be followed by a 1-month wash-out period. The primary efficacy criterion will be the change in motor and non-motor handicap scores on the Total Movement Disorders Society Unified Parki ...
Voir le projet
17
Participants partenaires
TERMINÉ
DC-based immunotherapy to treat Malignant Mesothelioma (H2020MM04)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
Asbestos is one of the major occupational carcinogens. The European Union has an extensive history of protecting workers and consumers against asbestos and even adopted a resolution 2012/2065(INI) ‘on asbestos related occupational health threats and prospects for abolishing all existing asbestos’ last year. Although asbestos is banned, it is still massively present in the built environment. Millio ...
Voir le projet
8
Participants partenaires
TERMINÉ
DIabetes REsearCh on patient sTratification (DIRECT)
Date du début: 1 févr. 2012, Date de fin: 31 janv. 2019,
The overarching aims of the DIRECT consortium, consisting of 20 leading academic groups in diabetes and 5 EFPIA companies, are to identify biomarkers that address current bottlenecks in diabetes drug development and to develop a stratified medicines approach to treatment of type 2 diabetes with either existing or novel therapies.There is heterogeneity in who develops diabetes, the rate at which th ...
Voir le projet
27
Participants partenaires
TERMINÉ
"Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance" (MON4STRAT)
Date du début: 1 févr. 2014, Date de fin: 31 janv. 2018,
...cable dose adjustments during treatment and thus (iii) to improve efficacy while reducing risk of EDR or adverse effects.The MON4STRAT approach will be validated through a prospective, multicentre, randomized clinical trial with150 adults. Its applicability in paediatrics will be tested through an observational study with 70 children/neonates.Being generic in nature, MON4STRAT will be replicable t ...
Voir le projet
13
Participants partenaires
TERMINÉ
European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke (EuroHYP-1)
Date du début: 1 févr. 2012, Date de fin: 31 janv. 2017,
The consortium led by UKER and EuroHYP, the European Stroke Research Network for Hypothermia, proposes a large, multicentre clinical trial which will assess mild hypothermia as a novel treatment for ischemic stroke.Stroke is the second cause of death world-wide and the second cause of lost disability-adjusted life years in high-income countries. Stroke incidence rises exponentially with age, so it ...
Voir le projet
38
Participants partenaires
TERMINÉ
A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease (NILVAD)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
Alzheimer’s disease (AD) is an ever-increasing public health concern among the aging population and is the most common form of dementia affecting more than 15 million individuals worldwide and around 5 million Europeans. The direct and indirect costs of AD and other dementias amount to more than €440,000 million each year (www.alz.org, 2010).Even modest therapeutic advances that delay disease onse ...
Voir le projet
17
Participants partenaires
TERMINÉ
Development of biophotonic device based on flexible light emitting textile dedicated to the monitoring and treatment for dermatologic diseases and carcinoma (PHOS-ISTOS)
Date du début: 1 déc. 2013, Date de fin: 30 nov. 2016,
The therapeutic effect of the photodynamic therapy (PDT) depends on a combination of parameters that include drug dose, drug-light interval, oxygen in cells and light irradiance rate. It also varies according to the wavelength distribution of the light source. Finally, a homogeneous and reproducible illumination during the clinical PDT is determinant in preventing under- or overtreatment. So, the ...
Voir le projet
12
Participants partenaires
TERMINÉ
Persistent virus infection as a cause of pathogenic inflammation in type 1 diabetes - an innovative research program of biobanks and expertise (PEVNET)
Date du début: 1 janv. 2011, Date de fin: 30 juin 2016,
"Type 1 diabetes is caused by an inflammatory process which damage insulin-producing beta-cells in the pancreas. It is one of the most common chronic diseases and its incidence is rapidly increasing. Due to its complications it causes a significant medical and economic burden to European society. A causal association between enterovirus and type 1 diabetes has become more and more likely. The aim ...
Voir le projet
14
Participants partenaires
TERMINÉ
INTERNATIONALISATION ET MODERNISATION EN SOINS INFIRMIERS HOSPITALIERS
Date du début: 1 juin 2015, Date de fin: 31 mai 2016,
The project is implemented by the Nursing ITEHO Jeanne d’Arc. It involves 10 teachers from the hospital section and 20 students of the 3rd year (21 years old) in a complementary secondary vocational education (3 years after a technical upper secondary education, vocational or general ) .
This mobility is an important feature to improve the education and training : it will give a European dimens ...
Voir le projet
8
Participants partenaires
TERMINÉ
Vertically integrated Array-type Mirau-based OCT System for early diagnostics of skin cancer (VIAMOS)
Date du début: 1 oct. 2012, Date de fin: 31 mai 2016,
Description
Skin cancer is the most commonly diagnosed type of cancer. Its early diagnosis is essential since it can be treated more effectively when detected earlier. Visual inspection followed by histological examination is, still today, the gold standard for clinicians. However, a large number of unnecessary surgical procedures are still ...
Voir le projet
10
Participants partenaires
TERMINÉ
Renforcement des compétences infirmières dans la dimension internationale
Date du début: 1 oct. 2014, Date de fin: 30 sept. 2015,
The project is implemented by the Nursing ITEHO Jeanne d?Arc. It involves 17 students of the 3rd year (21 years old) and 8 teachers from the hospital section in a complementary secondary vocational education (3 years after a technical upper secondary education, vocational or general ) .
This mobility is an important feature to improve the education and training : it will give a European dimension ...
Voir le projet
7
Participants partenaires
TERMINÉ
Regenerating Bone defects using New biomedical Engineering approaches (REBORNE)
Date du début: 1 janv. 2010, Date de fin: 30 juin 2015,
...m clinical trials using advanced biomaterials and cells triggering bone healing in patients. In order to reach this goal, five phase II clinical studies with 20 patients are proposed in 12 clinical centres spread in 8 European countries. Three orthopaedic trials concerning the treatment of long bone fractures and osteonecrosis of the femoral head in adults or children will be conducted using bioce ...
Voir le projet
24
Participants partenaires
TERMINÉ
Micro-Technologies and Systems for Robot-Assisted Laser Phonomicrosurgery (uRALP)
Date du début: 16 janv. 2012, Date de fin: 31 mars 2015,
Description
Micro-Technologies and Systems for Robot-assisted Laser PhonomicrosurgeryLasers form an increasingly common tool for precision treatment of pathological conditions on delicate and vital human organs. However, laser aiming control relies completely on the dexterity of surgeons. µRALP proposes a redesign of laser phonomicrosurge ...
Voir le projet
7
Participants partenaires
TERMINÉ
Health and Demographic Change (HDC)
Date du début: 31 déc. 2006, Date de fin: 29 juin 2013,
The goal of the project « HEALTH and DEMOGRAPHIC CHANGES » is to create a transnational centre of excellence in North-West Europe which. in the health field. responds to demographic change due to the ageing of the population. Expected Result ...
Voir le projet
8
Participants partenaires
TERMINÉ
THERAPEUTISCHE UND PRÄVENTIVE BILDUNGSMASSNAHMEN BEI DIABETES UND RISIKO-FETTSUCHT BEI ERWACHSENEN UND JUGENDLICHEN (EDUDORA 2)
Date du début: 31 mai 2009, Date de fin: 30 janv. 2013,
Ziel dieses Projekts ist die Einrichtung eines grenzüberschreitenden Netzes (Wallonien - Großherzog-tum Luxemburg - Lothringen) zur Verbesserung der Aus- und Weiterbildung des Pflegepersonals. Das Projekt konzentriert sich auf eine multidisziplinäre Schulung des Patienten und die Prävention bei Personen, die unter Diabetes oder Fettsucht mit hohem Diabetesrisiko leiden. Unter Berücksichtigung der ...
Voir le projet
8
Participants partenaires
TERMINÉ
Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children (LOULLA&PHILLA)
Date du début: 1 nov. 2008, Date de fin: 30 avr. 2012,
"Only for Children Pharmaceuticals, a French based Small and Medium-sized Enterprise (SME) developing drug for children, is the Coordinator of a multinational, multidisciplinary and complementary Consortium. This Consortium is composed of highly qualified organizations and notorious clinicians in pediatric hemato-oncology. The Consortium is an integrated team of competencies (clinicians, pædiatric ...
Voir le projet
12
Participants partenaires
TERMINÉ
Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics (Mitotarget)
Date du début: 1 févr. 2009, Date de fin: 31 mars 2012,
Mitochondrial dysfunction is a major hallmark of various neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s diseases or Amyotrophic Lateral Sclerosis (ALS). However linking mitochondrial dysfunction to the pathogenesis of some of these diseases still needs to be elucidated. Furthermore, in pathologies where this link is already established, the question re ...
Voir le projet
19
Participants partenaires
TERMINÉ
PATIENT SAFETY THROUGH INTELLIGENT PROCEDURES IN MEDICATION (PSIP)
Date du début: 1 janv. 2008, Date de fin: 31 juil. 2011,
Adverse Drug Events (ADE) due to product safety problems, and medication errors due to human factors (HF) are a major Public Health issue. They endanger the patients' safety and originate considerable extra hospital costs.Healthcare ICT applications should help reducing the prevalence of preventable ADE, by providing healthcare professionals and patients with relevant knowledge (guidelines, recomm ...
Voir le projet
13
Participants partenaires
TERMINÉ
Training professionals to bring together medical cultures in Europe : A training programme on a European scale for healthcare professionals, bringing together the different medical cultures of the continent. This project started in 2000 and lasted 36 months.
Voir le projet